摘要
目的:建立反相高效液相色谱法以测定入血浆及痰液中莫西沙星浓度,用于比较莫西沙星在血浆及支气管分泌物的分布情况。方法:以乙腈沉淀血浆和痰液中的蛋白质,采用YMC C18色谱柱(150mm×4.6mm,5μm),柱温为室温,流动相为乙腈-0.01mol·L^-1磷酸二氢钾(22:78),磷酸二氢钾用磷酸调节pH值至2.70,流速为1.0mL·min~^-1。以乳酸环丙沙星为内标,检测波长为296nm。结果:血浆样品中的莫西沙星在0.0781~10mg·L^-1范围内线性关系良好(r=0.9956,w=1/C^2);预处理回收率为90.45%~91.82%,方法回收率为96.91%~102.00%,日内RSD为1.17%~3.91%,日间RSD为1.84%~3.13%。痰液标本中的莫西沙星在0.1563~20mg·L^-1范围内线性关系良好(r=0.9913,W=1/C^2);预处理回收率88.01%~91.78%,方法回收率85.12%~114.27%,日内RSD为1.70%~5.26%,日间RSD为2.48%~4.56%。结论:本方法快速、灵敏、准确、简便,适用于盐酸莫西沙星的血浆及痰液中的浓度测定。
Objective:To develop a RP-HPLC method for determining the concentration of moxifloxacin in human plasma and sputum. Methods:The protein in plasma and sputum was precipitated by aeetonitrile,and subsequently quantified by a RP-HPLC equipped with a YMC C18 column (150mm×4.6mm,5μm). The samples were assayed at room temperature. The mobile phase consisted of aeetonitrile-0.01 mol·L^-1 potassium dihydrogen phosphate (22: 78, pH of buffer solution was adjusted to 2.70 by phosphoric acid). Flow rate was 1.0 mL·min^-1. The detection wavelength was set at 296 nm. Ciprofloxaein was used as the internal standard. Results:The linearity of calibrated curves of plasma sample was in the range of 0.078 1 -10 mg·L^-1(r=0.9956,w =1/C^2). The pretreatment recovery was 90.45% -91.82%The methodological recovery was 96.91% - 102.00%. The withinday RSDs were in the range of 1.17% -3.91% and inter-day RSDs of 1.84% -3.13%. The linearity of calibrated curves of sputum sample was in the range of 0. 156 3 -20 mg·L^-1(r = 0. 991 3,w = 1/C^2). The pretreatment recovery was 88.01% -91.78%. The methodological recovery was 85. 12% -114.27%. The within-day RSDs were in the range of 1.70% -5.26% and inter-day RSDs of 2.48% -4.56%. Conclusion:The sensitive,accurate and easily manipulated assay offered a satisfactory tool for the pharmaeokineties and relative bioavailability of moxifloxacin in plasma and sputum samples.
出处
《中国新药杂志》
CAS
CSCD
北大核心
2009年第15期1419-1423,共5页
Chinese Journal of New Drugs